Literature DB >> 7104191

Enhancing effect of pre-treatment of cells with misonidazole in hypoxia on their response to melphalan in air.

E Smith, I J Stratford, G E Adams.   

Abstract

Pre-treatment of hypoxic cells with misonidazole (MISO) can render these cells more sensitive to a subsequent treatment with melphalan. Results in this paper show that this enhancement (or chemopotentiation) depends on the contact time and concentration of MISO, on the melphalan concentration and also on the cultural history of the cells. Damage due to hypoxic pre-incubation in MISO can be repaired if cells are subsequently aerated at 37 degrees C. In contrast, for cells washed free of MISO and then held under N2 at 37 degrees C, repair is much slower. No repair occurs when cells are held in air at 0 degrees C. The kinetics and extent of repair were dependent on the cells prior culture. Thus for exponential cells repair was complete after approximately 4 h, whereas for plateau-phase cells and cells with prior chronic hypoxia, repair was only partially complete after this time. Dithiothreitol was shown to protect partially against the enhancement of melphalan toxicity. Increased cell killing is also obtained if cells are given high concentrations of MISO (50 mM) in air during exposure to melphalan.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7104191      PMCID: PMC2011057          DOI: 10.1038/bjc.1982.173

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  Electron affinic sensitization. V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles.

Authors:  J C Asquith; M E Watts; K Patel; C E Smithen; G E Adams
Journal:  Radiat Res       Date:  1974-10       Impact factor: 2.841

2.  Hypoxic sensitizers: radiobiological studies at the cellular level.

Authors:  E J Hall; L Roizin-Towle
Journal:  Radiology       Date:  1975-11       Impact factor: 11.105

3.  Radiosensitizing and toxic effects on the 2-nitroimidazole Ro-07-0582 in hypoxic mammation cells.

Authors:  B A Moore; B Palcic; L D Skarsgard
Journal:  Radiat Res       Date:  1976-09       Impact factor: 2.841

4.  Ro-07-0582 as a radiosensitizer and cytotoxic agent.

Authors:  E J Hall; J Biaglow
Journal:  Int J Radiat Oncol Biol Phys       Date:  1977 May-Jun       Impact factor: 7.038

Review 5.  A review of hypoxic cell radiosensitization in experimental tumors.

Authors:  J F Fowler; J Denekamp
Journal:  Pharmacol Ther       Date:  1979       Impact factor: 12.310

Review 6.  Protection against the toxicity of alkylating agents by thiols: the mechanism of protection and its relevance to cancer chemotherapy. A review.

Authors:  T A Connors
Journal:  Eur J Cancer       Date:  1966-12       Impact factor: 9.162

7.  Effect of hyperthermia on differential cytotoxicity of a hypoxic cell radiosensitizer, Ro-07-0582, on mammalian cells in vitro.

Authors:  I J Stratford; G E Adams
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640

8.  Some factors affecting the specific toxicity of misonidazole towards hypoxic mammalian cells.

Authors:  I J Stratford; P Gray
Journal:  Br J Cancer Suppl       Date:  1978-06

9.  Split dose cytotoxic experiments with misonidazole.

Authors:  I J Stratford
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

10.  Ascorbate anion potentiates cytotoxicity of nitro-aromatic compounds under hypoxic and anoxic conditions.

Authors:  C J Koch; R L Howell; J E Biaglow
Journal:  Br J Cancer       Date:  1979-03       Impact factor: 7.640

View more
  3 in total

1.  Distribution of nitroimidazoles and L-phenylalanine mustard in mammary adenocarcinoma 16/C tumors.

Authors:  P E Noker; L Simpson-Herren; S D Wagoner
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Cytotoxic effect of misonidazole and cyclophosphamide on aerobic and hypoxic cells in a C3H mammary carcinoma in vivo.

Authors:  C Grau; S M Bentzen; J Overgaard
Journal:  Br J Cancer       Date:  1990-01       Impact factor: 7.640

3.  The differential cytotoxicity of RSU 1069: cell survival studies indicating interaction with DNA as a possible mode of action.

Authors:  I J Stratford; J M Walling; A R Silver
Journal:  Br J Cancer       Date:  1986-03       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.